Research Report University Hospital for clinical assessment 20090160

Abstract

A Multicenter, Randomised, Double-blind, Placebo-controlled Study of Darbepoetin Alfa for the Treatment of Anaemic Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Keywords

• Myelodysplastic Syndrome
• darbepoetin alfa